MAIA Biotechnology, Inc.

MAIA · AMEX
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$8,903-$5,347-$4,517-$3,572
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$647$802$371$693
Change in WC$4,962$86$770$227
Other Non-Cash-$192$323-$826-$1,257
Operating Cash Flow-$3,487-$4,135-$4,202-$3,908
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$0$0$0
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$3,779$3,256$5,461$4,978
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$456$152$0-$133
Financing Cash Flow$4,235$3,408$5,461$4,845
Forex Effect-$1$8$3-$27
Net Chg. in Cash$747-$719$1,262$911
Supplemental Information
Beg. Cash$10,145$10,863$9,601$8,691
End Cash$10,892$10,145$10,863$9,601
Free Cash Flow-$3,487-$4,135-$4,202-$3,908
MAIA Biotechnology, Inc. (MAIA) Financial Statements & Key Stats | AlphaPilot